Article Information
History
- July 6, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Allison W Watts, Research Manager1,
- Louise C Mâsse, Professor2,
- David M Goldfarb, Clinical Associate Professor3,
- Michael A Irvine, Senior Scientist4,
- Sarah M Hutchison, Postdoctoral Fellow1,
- Lauren Muttucomaroe, Research Coordinator1,
- Bethany Poon, Research Assistant1,
- Vilte E Barakauskas, Clinical Associate Professor3,
- Collette O’Reilly, Director of Risk Management5,
- Else S Bosman, Database Manager1,
- Frederic Reicherz, Post-doctoral Fellow1,
- Daniel Coombs, Professor6,
- Mark Pitblado, Undergraduate student1,
- Sheila F O’Brien, Associate Director7 and
- Pascal M Lavoie, Professor1,#
- 1BC Children’s Hospital Research Institute, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, Canada V5Z 4H4
- 2School of Population and Public Health, University of British Columbia, Vancouver, Canada, V6T 1Z3
- 3Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada, V5Z 4H4
- 4British Columbia Centre for Disease Control, Vancouver, Canada, V5Z 4R4
- 5Vancouver School District, Vancouver, Canada, V6J 5K8
- 6Department of Mathematics and Institute of Applied Mathematics, University of British Columbia, Vancouver, Canada, V6T 1Z2
- 7Epidemiology & Surveillance, Canadian Blood Services, Ottawa, Canada, K1J 4J5
- ↵#Corresponding author:
Dr. Pascal M. Lavoie, BC Children’s Hospital Research Institute, 4th Floor, Translational Research Building, 950 West 28th Avenue, Vancouver, British Columbia, V5Z 4H4, Canada, Email: plavoie{at}bcchr.ca, Fax: +1-604-875-3106
Posted July 06, 2022.
SARS-CoV-2 seroprevalence among public school staff in Metro Vancouver after the first Omicron wave in British Columbia, Canada
